ADC Therapeutics SA Debt-to-Equity Ratio Growth & History (ADCT)
ADC Therapeutics SA's debt-to-equity ratio was 0.31 for fiscal 2022.
View full ADC Therapeutics SA company overviewADC Therapeutics SA annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2022 | 2022-12-31 | 0.31 | −0.30 | −48.86% |
| 2021 | 2021-12-31 | 0.61 | 0.49 | +390.87% |
| 2020 | 2020-12-31 | 0.12 | 0.08 | +175.75% |
| 2019 | 2019-12-31 | 0.05 | 0.00 | +5.36% |
| 2018 | 2018-12-31 | 0.04 | — | — |
ADC Therapeutics SA quarterly debt-to-equity ratio
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2023 | 2023-03-31 | 0.33 | −0.30 | −47.80% |
| Q4 2022 | 2022-12-31 | 0.31 | −0.30 | −48.86% |
| Q3 2022 | 2022-09-30 | 0.07 | −0.47 | −86.76% |
| Q2 2022 | 2022-06-30 | 0.90 | 0.49 | +119.71% |
| Q1 2022 | 2022-03-31 | 0.63 | 0.47 | +293.03% |
| Q4 2021 | 2021-12-31 | 0.61 | 0.49 | +390.87% |
| Q3 2021 | 2021-09-30 | 0.54 | — | — |
| Q2 2021 | 2021-06-30 | 0.41 | — | — |
| Q1 2021 | 2021-03-31 | 0.16 | — | — |
| Q4 2020 | 2020-12-31 | 0.12 | 0.08 | +175.75% |
| Q4 2019 | 2019-12-31 | 0.05 | — | — |
ADC Therapeutics SA debt-to-equity ratio trends
Between the periods ended 2018-12-31 and 2022-12-31, ADC Therapeutics SA's debt-to-equity ratio increased from 0.04 to 0.31, a change of 0.27. The latest reported quarter, Q1 2023, shows 0.33.
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ADC Therapeutics SA source filings ↗